Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 29-Jul-2022 titled Alembic Pharmaceuticals announces its wholly owned subsidiary, Aleor Dermaceuticals Limited receives USFDA Final Approval for Diclofenac Sodium Topical Gel, 3%